Muscarinic acetylcholine receptor but not nicotinic acetylcholine receptor plays a role in morphine-induced behavioral sensitization in rats

Sun, Jun-hong; Tian, Lin; Cui, Ruisi; Ruan, Heng; Li, Xinwang

doi:10.1016/j.pbb.2017.08.005

Cited by 6 publications

(1 citation statement)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For hyperlocomotion test, METH (2.0 mg/kg) [ 29 ], cocaine (10.0 mg/kg) [ 30 ], morphine (5.0 mg/kg) [ 31 ] and MK-801 (1.0 mg/kg) [ 32 ] were each administered via intraperitoneal (i.p.) injection, while SCH and RAC were intraperitoneally injected 30 min before METH injection at doses of 0.03 mg/kg and 2.0 mg/kg, respectively [ 33 , 34 ].…”

Section: Methodsmentioning

confidence: 99%

A novel microRNA, novel-m009C, regulates methamphetamine rewarding effects

Zhu

Yan

et al. 2022

Mol Psychiatry

View full text Add to dashboard Cite

Methamphetamine (METH) is a widely abused psychostimulant, whose hyper-rewarding property is believed to underlie its addictive effect, but the molecular mechanism regulating this effect remains unclear. We previously reported that decreased expression of a novel microRNA (miRNA), novel-m009C, is implicated in the regulation of METH hyperlocomotion. Here, we found that novel-m009C may be homologous to hsa-miR-604. Its expression is consistently downregulated in the nucleus accumbens (NAc) of mice when exposed to METH and cocaine, whereas significant alterations in novel-m009C expression were not observed in the NAc of mice subjected to other rewarding and psychiatric stimuli, such as sucrose, morphine and MK-801. We further found the substantial reduction in novel-m009C expression may be regulated by both dopamine receptor D1 (D1R) and D2 (D2R). Increasing novel-m009C levels in the NAc attenuated METH-induced conditioned place preference (CPP) and hyperlocomotion, whereas inhibiting novel-m009C expression in the NAc enhanced these effects but did not change the preference of mice for a natural reward, i.e., sucrose. These effects may involve targeting of genes important for the synaptic transmission, such as Grin1 (NMDAR subunit 1). Our findings demonstrate an important role for NAc novel-m009C in regulating METH reward, reveal a novel molecular regulator of the actions of METH on brain reward circuitries and provide a new strategy for treating METH addiction based on the modulation of small non-coding RNAs.

show abstract